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The most common reasons for presentation immediately after a massive earthquake 
that hit eastern Japan on 11 March 2011 were reported to be the need for repeat routine 
medications, upper respiratory-tract infections, and insomnia apparently related to 
increased stress [1]. Around one month after the disaster, we suspected that 
environmental fungi present in the air because of the collapse of houses may affect the 
respiratory conditions of local residents rather than asbestos. 
Saiseikai Kanazawa Hospital Medical Relief Team arrived at Ogatsu near 
Ishinomaki City on 16 April 2011. There was still a great deal of scattered debris on the 
ground. Our medical team visited Mizuhama refuge that stood near the inlet. About 20 
people had begun living there temporarily. Many previously healthy people began to 
suffer from non-productive cough. 
Significant progress has been made in understanding cough over the past 10 years [2]. 
In addition, the cause of chronic cough in each patient will be diagnosed based on 
numerous treatment guidelines under ordinary conditions. In a tsunami-affected town, it 
may be assumed that cough symptoms may not be treated successfully because of 
inadequate assessment and poor compliance with therapy. In fact, although previously 
arriving medical teams prescribed various medications (such as clarithromycin, 
antitussive drugs, histamine H1 antagonists, inhaled corticosteroids, bronchodilators, 
and proton-pomp inhibitors) during this period, the cough symptoms of these patients 
had not yet subsided. Therefore, the high prevalence of unexplained chronic cough 
(UCC) [3] seemed not to be due to the inconvenient conditions but to the ineffective 
therapy. 
The common respiratory manifestations on our arrival were mainly a sensation of 
something being stuck in throat and sometimes small amounts of clear bronchial 
production following attacks of coughing. These clinical features are included in those 
of fungus-associated chronic cough (FACC) [4]. Petri dishes with Sabouraud’s agar 
medium were exposed on the floor of the refuge, and Aspergillus fumigatus, Aspergillus 
flavus, and basidiomycetous fungi [5] colonized the plates. The fungal cultures obtained 
from the sputum of 6 patients (46.2%) under informed consent showed almost the same 
fungal profile (Aspergillus fumigatus 66.7%, Aspergillus flavus 33.3%, and 
basidiomycetous fungi 33.3%) as the environmental survey. A low dose of itraconazole 
therapy (50 mg/day for 14 days) [4] showed excellent efficacy for the respiratory 
symptoms in these cases. Thus, some patients with UCC were possibly diagnosed as 
having FACC. 
The outbreak of respiratory disorder in the refuge has subsided. Our clinical 
experience indicated that the new clinical concept of FACC has some advantages in 
managing UCC in a tsunami-affected town. 
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